No Data
No Data
Express News | Skye Bioscience Inc : Oppenheimer Cuts Target Price to $21 From $25
Why Skye Bioscience Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Skye Bioscience, Inc. (NASDAQ:SKYE) fell sharply during Monday's session after the company announced its SBI-100 Ophthalmic Emulsion Phase 2a trial did not achieve target product profile and
Skye Bioscience Pulls Plug on Glaucoma Drug, Stock Tumbles 15%
Sector Update: Health Care Stocks Decline Premarket Monday
Health care stocks were declining premarket Monday as the iShares Biotechnology ETF (IBB) was 0.5% lower and the Health Care Select Sector SPDR Fund (XLV) was down 0.3% recently. Skye Bioscience (SKYE
Sector Update: Health Care
Health care stocks were flat to lower premarket Monday, with the iShares Biotechnology ETF (IBB) inactive and the Health Care Select Sector SPDR Fund (XLV) down 0.3%. Skye Bioscience (SKYE) shares wer
Market-Moving News for June 10th
DSY: 255% | Big Tree Cloud shares are trading higher following the completion of the company's business combination with Plutonian Acquisition Corp. and amid continued volatility following its Nasdaq
Skinny bulldogOP : Look at the other company in the same industry you will know. The problem is, how high it can go.